Speakers

 

 

Key Speakers in 2018
 

Lord James (Jim) O’Neil, Honorary Professor of Economics at the University of Manchester & author of AMR review UK Lord James (Jim) O’Neil
Honorary Professor of Economics
University of Manchester & Author of AMR Review UK

Ana Maria Henao-Restrepo MD, Team Leader, Implementation Research Initiative for Vaccine Research, WHO Ana Maria Henao-Restrepo MD
Team Leader, Implementation Research Initiative for Vaccine Research
WHO

Emily Erbelding, M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH Dr Merlin Robb
Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP
U.S. Military HIV Research Program

Dr Melanie Saville, Director of Vaccine Development, CEPI Dr Melanie Saville
Director of Vaccine Development
CEPI

Dr Thomas G. Evans, CEO, Vaccitech Dr Thomas G. Evans
CEO
Vaccitech

Dr Laszlo Radvanyi, Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology, EMD Serono Dr Laszlo Radvanyi
Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology
EMD Serono

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Ruxandra Draghia-Akli, Vice President of Vaccines Public Health & Scientific Affairs, Merck (MSD) Sarah Gilbert
Professor of Vaccinology 
University of Oxford

Dr Wayne Koff, President & CEO, The Human Vaccines Project Dr Wayne Koff
President & CEO
The Human Vaccines Project

Professor Helen McShane, Professor of Vaccinology, Jenner Institute, Oxford University Professor Helen McShane
Professor of Vaccinology, Jenner Institute
Oxford University

Agenus Inc Dr Alex Duncan
Chief Technology Officer and Head of Research
Agenus Inc

 

 

 

 

ALL 2018 SPEAKERS
 

Dr Dicky Abraham, Executive Director/Distinguished Scientist, Merck, United States

Dr Dicky Abraham | Executive Director/Distinguished Scientist | Merck » speaking at Vaccine Europe

Prof Jeffrey Almond, Former Vice President Discovery Research and Development, Sanofi and Visiting Professor, University of Oxford - Oxford Vaccine Group, United Kingdom

Prof Jeffrey Almond | Former Vice President Discovery Research and Development, Sanofi and Visiting Professor | University of Oxford - Oxford Vaccine Group » speaking at Vaccine Europe

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer, United States

Dr Annaliesa Anderson | Vice President and CSO Bacterial Vaccines | Pfizer » speaking at Vaccine Europe

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial, France

Dr Jean-Christophe Audonnet | Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI | Merial » speaking at Vaccine Europe

Dr Joeri Auwerx, Director, Discovery Research, ViroVet N.V., Belgium

Dr Joeri Auwerx | Director, Discovery Research | ViroVet N.V. » speaking at Vaccine Europe

Dr Lorne Babiuk, Former Vice President Research, University of Alberta, Canada

Dr Lorne Babiuk | Former Vice President Research | University of Alberta » speaking at Vaccine Europe

Dr Frank Baehner, Area Head Prophylactic Vaccines, CureVac, Germany

Dr Frank Baehner | Area Head Prophylactic Vaccines | CureVac » speaking at Vaccine Europe

Dr Carl Barrett, Vice President of Translational Sciences, AstraZeneca Pharmaceuticals, United States

Dr Carl Barrett | Vice President of Translational Sciences | AstraZeneca Pharmaceuticals » speaking at Vaccine Europe

Dr Philip Beer, Physician Scientist and Precision Oncology Specialist, Sanger Institute, United Kingdom

Dr Philip Beer | Physician Scientist and Precision Oncology Specialist | Sanger Institute » speaking at Vaccine Europe

Professor Fernando M. A. Bernardo, Chief of Veterinary Office, Portugal, DGAV, The Portuguese National Authority for Animal Health, Portugal

Professor Fernando M. A. Bernardo | Chief of Veterinary Office, Portugal | DGAV, The Portuguese National Authority for Animal Health » speaking at Vaccine Europe

Dr Todd Black, Executive Director, Infectious Diseases, MSD, United States

Dr Todd Black | Executive Director, Infectious Diseases | MSD » speaking at Vaccine Europe

Prof Marc Bonten, Professor, UMC Utrecht, Netherlands

Prof Marc Bonten | Professor | UMC Utrecht » speaking at Vaccine Europe

Dr Maximilian Bosch, Medical Scientific Director, Pantec Biosolutions, Liechtenstein

Dr Maximilian Bosch | Medical Scientific Director | Pantec Biosolutions » speaking at Vaccine Europe

Prof Anne Botteaux, Molecular Bacteriology Laboratory, Universite Libre De Bruxelles, Belgium

Prof Anne Botteaux | Molecular Bacteriology Laboratory | Universite Libre De Bruxelles » speaking at Vaccine Europe

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK, France

Dr Anissa Boumlic-Courtade | Vaccine Market Lead, EMEA | MERCK » speaking at Vaccine Europe

Dr Helen Bright, Director, Flu Biopharm Development, MedImmune, United Kingdom

Dr Helen Bright | Director, Flu Biopharm Development | MedImmune » speaking at Vaccine Europe

Dr Kate Broderick, Vice President, Research and Development, Inovio Pharmaceuticals, United States

Dr Kate Broderick | Vice President,  Research and Development | Inovio Pharmaceuticals » speaking at Vaccine Europe

Adam Buckley, VP Business Development, VBI Vaccines, United States

Adam Buckley | VP Business Development | VBI Vaccines » speaking at Vaccine Europe

Dr Rosario Bullido, Head of Vet Inmuno Medicines Assessment Unit, Aemps, Spain

Dr Rosario Bullido | Head of Vet Inmuno Medicines Assessment Unit | Aemps » speaking at Vaccine Europe

Dr Miles Carroll, Deputy Director, Public Health England, United Kingdom

Dr Miles Carroll | Deputy Director | Public Health England » speaking at Vaccine Europe

Dr Senyon Choe, President of Mogam Institute for Biomedical Research & Professor, U.C.S.D., United States

Dr Senyon Choe | President of Mogam Institute for Biomedical Research & Professor | U.C.S.D. » speaking at Vaccine Europe

Ashok Chopra, Distingushed Professor, University of Texas Medical Branch, United States

Ashok Chopra | Distingushed Professor | University of Texas Medical Branch » speaking at Vaccine Europe

Prof Dennis Christensen, Head of Vaccine Adjuvant Research grp., Dept. Infectious Disease Immunology, Statens Serum Institute - Denmark, Denmark

Prof Dennis Christensen | Head of Vaccine Adjuvant Research grp., Dept. Infectious Disease Immunology | Statens Serum Institute - Denmark » speaking at Vaccine Europe

Dr Chris Clarke, Global Medical Affairs Director, GSK Vaccines, Belgium

Dr Chris Clarke | Global Medical Affairs Director | GSK Vaccines » speaking at Vaccine Europe

Dr Ralf Clemens, SVP, Grid Rio, Germany

Dr Ralf Clemens | SVP | Grid Rio » speaking at Vaccine Europe

Dr Jeffrey Cohen, Chief of Laboratory of Infectious Diseases, NIH, United States

Dr Jeffrey Cohen | Chief of Laboratory of Infectious Diseases | NIH » speaking at Vaccine Europe

Professor Louise Cosby, Head of Virology, Agri-Food and Biosciences Institute, United Kingdom

Professor Louise Cosby | Head of Virology | Agri-Food and Biosciences Institute » speaking at Vaccine Europe

Marc Andre D Aoust, Vice President of Research and Innovation, Medicago, Canada

Marc Andre D Aoust | Vice President of Research and Innovation | Medicago » speaking at Vaccine Europe

Prof Ron Dagan, head, pediatric Infectious diseases, Ben Gurion University, Israel

Prof Ron Dagan | head, pediatric Infectious diseases | Ben Gurion University » speaking at Vaccine Europe

Morena D'Alise, Lead Immunologist, Nouscom, Italy

Morena D'Alise | Lead Immunologist | Nouscom » speaking at Vaccine Europe

Michel De Baar, Executive Director BD & Licensing Europe, MSD, United Kingdom

Michel De Baar | Executive Director BD & Licensing Europe | MSD » speaking at Vaccine Europe

Dr Isabel de la Mata, Principal Advisor for Health and Crisis management, European Commission, Belgium

Dr Isabel de la Mata | Principal Advisor for Health and Crisis management | European Commission » speaking at Vaccine Europe

Dr Evelyna Derhovanessian, Senior Scientist, BioNTech Ag, Germany

Dr Evelyna Derhovanessian | Senior Scientist | BioNTech Ag » speaking at Vaccine Europe

Dr Dimitri Diavatopoulos, Department of Pediatrics/ Laboratory of Pediatric Infectious Diseases (LPID), Radboud Center for Infectious Diseases, Netherlands

Dr Dimitri Diavatopoulos | Department of Pediatrics/ Laboratory of Pediatric Infectious Diseases (LPID) | Radboud Center for Infectious Diseases » speaking at Vaccine Europe

Dr Thomas G. Evans, Vaccitech, United Kingdom

Dr Thomas G. Evans |  | Vaccitech » speaking at Vaccine Europe

Dr Ali Fattom, Sr. VP of Vaccines Research and Development, BlueWillow Biologics, United States

Dr Ali Fattom | Sr. VP of Vaccines Research and Development | BlueWillow Biologics » speaking at Vaccine Europe

Dr Martin Friede, Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department, WHO, Switzerland

Dr Martin Friede | Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department | WHO » speaking at Vaccine Europe

Roman Galetto, Group Lead, Preclinical Manager, Cellectis Therapeutics, France

Roman Galetto | Group Lead, Preclinical Manager | Cellectis Therapeutics » speaking at Vaccine Europe

Kirsty Gapp, Global Business Manager Transdermal and Microneedle Drug Delivery, 3M, United Kingdom

Kirsty Gapp | Global Business Manager Transdermal and Microneedle Drug Delivery | 3M » speaking at Vaccine Europe

Christiane Gerke, Head of Vaccine Programs, Institut Pasteur, France

Christiane Gerke | Head of Vaccine Programs | Institut Pasteur » speaking at Vaccine Europe

Dr Arin Ghasparian, CEO, Virometix AG, Switzerland

Dr Arin Ghasparian | CEO | Virometix AG » speaking at Vaccine Europe

Sarah Gilbert, Professor of Vaccinology, University of Oxford, United Kingdom

Sarah Gilbert | Professor of Vaccinology | University of Oxford » speaking at Vaccine Europe

Dr David Gilham, Vice President of Research and Development, Celyad, Belgium

Dr David Gilham | Vice President of Research and Development | Celyad » speaking at Vaccine Europe

Dr Gregory Glenn, President, Research and Development, Novavax, United States

Dr Gregory Glenn | President, Research and Development | Novavax » speaking at Vaccine Europe

Cori Gorman, Vice President Of Precision Medicine & Manufacturing, Agenus, unknown

Cori Gorman | Vice President Of Precision Medicine & Manufacturing | Agenus » speaking at Vaccine Europe

Dr Farshad Guirakhoo, CSO, GeoVax, Inc., United States

Dr Farshad Guirakhoo | CSO | GeoVax, Inc. » speaking at Vaccine Europe

Professor Carlos A. Guzman, Head of the Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research (HZI), Germany

Professor Carlos A. Guzman | Head of the Department of Vaccinology and Applied Microbiology | Helmholtz Centre for Infection Research (HZI) » speaking at Vaccine Europe

Dr Bassam Hallis, Head of Pre Clinical Development and General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis | Head of Pre Clinical Development and General Project Manager | Public Health England » speaking at Vaccine Europe

Prof Mark Hatherill, Professor, S.A. Tuberculosis Vaccine Initiative, South Africa

Prof Mark Hatherill | Professor | S.A. Tuberculosis Vaccine Initiative » speaking at Vaccine Europe

Professor John Hayball, Professor, University of South Australia, Australia

Professor John Hayball | Professor | University of South Australia » speaking at Vaccine Europe

Professor Peter Heegaard, Professor, National Veterinary Institute Technical University of Denmark, Denmark

Professor Peter Heegaard | Professor | National Veterinary Institute Technical University of Denmark » speaking at Vaccine Europe

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organisation, Switzerland

Ana Maria Henao Restrepo | Implementation Research and Economic Analysis, Initiative for Vaccine Research | World Health Organisation » speaking at Vaccine Europe

Dr Hanjo Hennemann, Chief Scientific Officer and Co Founder, VEROVACCiNES, Germany

Dr Hanjo Hennemann | Chief Scientific Officer and Co Founder | VEROVACCiNES » speaking at Vaccine Europe

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited, United Kingdom

David Hipkiss | Chief Executive Officer | Enesi Pharma Limited » speaking at Vaccine Europe

Dr Tim Hirst, CEO, GPN Vaccines, Australia

Dr Tim Hirst | CEO | GPN Vaccines » speaking at Vaccine Europe

Dr Karin Hoelzer, Senior Officer, The Pew Charitable Trusts, United States

Dr Karin Hoelzer | Senior Officer | The Pew Charitable Trusts » speaking at Vaccine Europe

Dr Mark Howarth, Professor, University of Oxford, United Kingdom

Dr Mark Howarth | Professor | University of Oxford » speaking at Vaccine Europe

Professor Dirk Jager, Managing Director, University Hospital of Heidelberg, Germany

Professor Dirk Jager | Managing Director | University Hospital of Heidelberg » speaking at Vaccine Europe

Konrad Janik, Acting Medical Manager, Institute of Sera Biotechnology & Vaccines BIOMED, Poland

Konrad Janik | Acting Medical Manager | Institute of Sera Biotechnology & Vaccines BIOMED » speaking at Vaccine Europe

Dr Jan Jezek, Chief Scientific Officer, Arecor Ltd, United Kingdom

Dr Jan Jezek | Chief Scientific Officer | Arecor Ltd » speaking at Vaccine Europe

Professor Gregers Jungersen, Professor of Veterinary Immunology and Vaccinology, Technical University of Denmark, Denmark

Professor Gregers Jungersen | Professor of Veterinary Immunology and Vaccinology | Technical University of Denmark » speaking at Vaccine Europe

Professor Lana Kandalaft, Director, Center of Experimental Therapeutics, University of Lausanne, Switzerland

Professor Lana Kandalaft | Director, Center of Experimental Therapeutics | University of Lausanne » speaking at Vaccine Europe

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals, United States

Dr Maria Karasarides | Executive Director, ImmunoOncology | Regeneron Pharmaceuticals » speaking at Vaccine Europe

Paula Kinnunen, Research Director, Food Safety Authority Evira, Finland

Paula Kinnunen | Research Director | Food Safety Authority Evira » speaking at Vaccine Europe

Dr Olivier Kitten, Chief Executive Officer, Affilogic, France

Dr Olivier Kitten | Chief Executive Officer | Affilogic » speaking at Vaccine Europe

Dr Elizabeth Klemm, Project Officer, Wellcome Trust, United Kingdom

Dr Elizabeth Klemm | Project Officer | Wellcome Trust » speaking at Vaccine Europe

Dr Wayne Koff, President and CEO, The Human Vaccines Project, United States

Dr Wayne Koff | President and CEO | The Human Vaccines Project » speaking at Vaccine Europe

Dr Alexander Kort, SVP Corporate Development, Themis Bioscience GmbH, Austria

Dr Alexander Kort | SVP Corporate Development | Themis Bioscience GmbH » speaking at Vaccine Europe

Professor Jeroen Kortekaas, Wageningen University, Netherlands

Professor Jeroen Kortekaas |  | Wageningen University » speaking at Vaccine Europe

Greg Kulnis, Business Development Director, Covance, United States

Greg Kulnis | Business Development Director | Covance » speaking at Vaccine Europe

Carlos Pinero Lambea, Researcher, Centre for Genomic Regulation, Spain

Carlos Pinero Lambea | Researcher | Centre for Genomic Regulation » speaking at Vaccine Europe

Nathalie Landry, Executive Vice President, Scientific & Medical Affairs, Medicago, Canada

Nathalie Landry | Executive Vice President, Scientific & Medical Affairs | Medicago » speaking at Vaccine Europe

Dr Yotam Levin, Chief Executive Officer, NanoPass Technologies, Israel

Dr Yotam Levin | Chief Executive Officer | NanoPass Technologies » speaking at Vaccine Europe

Maria Lluch Senar, Co-Cordinator, Centre for Genomic Regulation, Spain

Maria Lluch Senar | Co-Cordinator | Centre for Genomic Regulation » speaking at Vaccine Europe

Dr Stephen Lockhart, Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD), Pfizer, United Kingdom

Dr Stephen Lockhart | Vice President and Head of Europe and Asia-Pacific Vaccine Clinical Research and Development (VCRD) | Pfizer » speaking at Vaccine Europe

Dr Patricia Londono-Hayes, Sr. Director / Head R&D Initiatives, Europe, Sanofi, France

Dr Patricia Londono-Hayes | Sr. Director / Head  R&D Initiatives, Europe | Sanofi » speaking at Vaccine Europe

Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences, Netherlands

Alfred Luitjens | Director Cell Technology at Batavia Biosciences | Batavia Biosciences » speaking at Vaccine Europe

Dr Anthony Simon Lynch, Senior Scientific Director, Janssen R&D, Netherlands

Dr Anthony Simon Lynch | Senior Scientific Director | Janssen R&D » speaking at Vaccine Europe

Pedro Madureira, CSO, Immunethep, Portugal

Pedro Madureira | CSO | Immunethep » speaking at Vaccine Europe

Dr Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership, Netherlands

Dr Michael Makanga | Executive Director | European and Developing Countries Clinical Trials Partnership » speaking at Vaccine Europe

Dr Anna-Karin Maltais, Chief Scientific Officer, Eurocine Vaccines AB, Sweden

Dr Anna-Karin Maltais | Chief Scientific Officer | Eurocine Vaccines AB » speaking at Vaccine Europe

Dr Michael Manns, Professor, Hannover Medical School, Germany

Dr Michael Manns | Professor | Hannover Medical School » speaking at Vaccine Europe

Dr Victor Mbao, Senior Program Specialist, International Development Research Centre, Kenya

Dr Victor Mbao | Senior Program Specialist | International Development Research Centre » speaking at Vaccine Europe

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc., United States

Dr Douglas Mcneel | Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board | Madison Vaccines Inc. » speaking at Vaccine Europe

Professor Helen Mcshane, Professor Of Vaccinology Wellcome Senior Fellow PI Head Of TB Vaccines Group, The Jenner Institute - University of Oxford, United Kingdom

Professor Helen Mcshane | Professor Of Vaccinology Wellcome Senior Fellow PI Head Of TB Vaccines Group | The Jenner Institute - University of Oxford » speaking at Vaccine Europe

Dr Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals, Netherlands

Dr Kees Melief | Chief Scientific Officer | I.S.A. Pharmaceuticals » speaking at Vaccine Europe

Dr Maria Mellado, Application Specialist, Puritifcation Technologies, Sartorius Stedim Biotech, Spain

Dr Maria Mellado | Application Specialist, Puritifcation Technologies | Sartorius Stedim Biotech » speaking at Vaccine Europe

Prof Kingston Mills, Professor of Experimental Immunology, Trinity College Dublin, Ireland

Prof Kingston Mills | Professor of Experimental Immunology | Trinity College Dublin » speaking at Vaccine Europe

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi, Italy

Prof Emanuele Montomoli | Prof in Public Health University of Siena & CSO | VisMederi » speaking at Vaccine Europe

Dr Geert Mudde, Chief Scientific Officer and Founder, OncoQR ML, Austria

Dr Geert Mudde | Chief Scientific Officer and Founder | OncoQR ML » speaking at Vaccine Europe

Dr Tarit Mukhopadhyay, Senior Lecturer of Vaccine Bioprocess Development, University College London, United Kingdom

Dr Tarit Mukhopadhyay | Senior Lecturer of Vaccine Bioprocess Development | University College London » speaking at Vaccine Europe

Dr Mel Munro, Project Manager, Biologicals Regulatory Affairs, Triveritas Limited, United Kingdom

Dr Mel Munro | Project Manager, Biologicals Regulatory Affairs | Triveritas Limited » speaking at Vaccine Europe

Imraan Munshi, Global Communications Lead, Vaccines, MSD, United States

Imraan Munshi | Global Communications Lead, Vaccines | MSD » speaking at Vaccine Europe

Andreas Neubert, Vice President Vaccines, IDT Biologika, Germany

Andreas Neubert | Vice President Vaccines | IDT Biologika » speaking at Vaccine Europe

Claire Nguyen Le, Exec Director, Clinical Development, Syneos Health, France

Claire Nguyen Le | Exec Director, Clinical Development | Syneos Health » speaking at Vaccine Europe

Dr Mikkel Nissum, Technical Development Leader, GSK Vaccine, Italy

Dr Mikkel Nissum | Technical Development Leader | GSK Vaccine » speaking at Vaccine Europe

Lord Jim O'Neill, Honorary Professor of Economics at the University of Manchester & author of AMR review UK, The University of Manchester, United Kingdom

Lord Jim O'Neill | Honorary Professor of Economics at the University of Manchester & author of AMR review UK | The University of Manchester » speaking at Vaccine Europe

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Netherlands

Prof Ab Osterhaus | Director, Research Center for Emerging Infections and Zoonoses (RIZ) | University of Veterinary Medicine Hannover » speaking at Vaccine Europe

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Netherlands

Prof Ab Osterhaus | Director, Research Center for Emerging Infections and Zoonoses (RIZ) | University of Veterinary Medicine Hannover » speaking at Vaccine Europe

Dr Arto Palmu, Research manager, head of Clinical Research Team, Public Health Evaluation and Projection Unit, Department of Public Health Solu, Finnish National Institute for Health and Welfare, Finland

Dr Arto Palmu | Research manager, head of Clinical Research Team, Public Health Evaluation and Projection Unit, Department of Public Health Solu | Finnish National Institute for Health and Welfare » speaking at Vaccine Europe

Dr Cristina Peixoto, Head of Downstream Process A.C.T.U., iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Dr Cristina Peixoto | Head of Downstream Process A.C.T.U. | iBET – Instituto de Biologia Experimental e Tecnológica » speaking at Vaccine Europe

Yoav Peretz, Global Scientific Director, Flow Cytometry, Covance, Canada

Yoav Peretz | Global Scientific Director, Flow Cytometry | Covance » speaking at Vaccine Europe

Dr Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation, United States

Dr Gregory Poland | Director of Mayo Vaccine Research Group | Mayo Clinic and Foundation » speaking at Vaccine Europe

Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen, Netherlands

Dr Jan Poolman | Head Bacterial Vaccine Discovery and Early Development | Janssen » speaking at Vaccine Europe

Andrew Potter, CEO, VIDO-InterVac, Canada

Andrew Potter | CEO | VIDO-InterVac » speaking at Vaccine Europe

Geert Preuveneers, Head of Regulatory Affairs Europe, MSD, Belgium

Geert Preuveneers | Head of Regulatory Affairs Europe | MSD » speaking at Vaccine Europe

Prof Roman Prymula, Professor Preventive Medicine, Charles University in Prague, Czech Republic

Prof Roman Prymula | Professor Preventive Medicine | Charles University in Prague » speaking at Vaccine Europe

Dr Ahmadur Rahman, Senior Clinical Director Oncology, MSD, United Kingdom

Dr Ahmadur Rahman | Senior Clinical Director Oncology | MSD » speaking at Vaccine Europe

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines, United States

Dr Rino Rappuoli | Chief Scientist | GSK Vaccines » speaking at Vaccine Europe

Prof Robert Read, Head of Academic Unit - Clinical and Experimental Sciences, Professor of Infectious Diseases, Honorary Consultant Physician, University of Southampton, United Kingdom

Prof Robert Read | Head of Academic Unit - Clinical and Experimental Sciences, Professor of Infectious Diseases, Honorary Consultant Physician | University of Southampton » speaking at Vaccine Europe

Dr Merlin Robb, Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP, U.S. Military HIV Research Program, United States

Dr Merlin Robb | Deputy Director MHRP for Clinical Research, Director, HJF Component of MHRP | U.S. Military HIV Research Program » speaking at Vaccine Europe

Antonio Roldao, Senior Researcher, iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Antonio Roldao | Senior Researcher | iBET – Instituto de Biologia Experimental e Tecnológica » speaking at Vaccine Europe

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines, United States

Dr Jerald Sadoff | Senior Advisor Vaccine Development | Janssen Infectious Diseases and Vaccines » speaking at Vaccine Europe

Michael Salter, R&D Facilitator, A.B. Agri, United Kingdom

Michael Salter | R&D Facilitator | A.B. Agri » speaking at Vaccine Europe

Dr Adel Samson, Lead, Translational Cancer Immunotherapy Group, University of Leeds, United Kingdom

Dr Adel Samson | Lead, Translational Cancer Immunotherapy Group | University of Leeds » speaking at Vaccine Europe

Dr Melanie Saville, Director Vaccine Development, CEPI, France

Dr Melanie Saville | Director Vaccine Development | CEPI » speaking at Vaccine Europe

Dr Hanneke Schuitemaker, Vice President and Head of Viral Vaccine Discovery and Translational Medicine, Janssen, Netherlands

Dr Hanneke Schuitemaker | Vice President and Head of Viral Vaccine Discovery and Translational Medicine | Janssen » speaking at Vaccine Europe

Dr Joerg (Jörg) Schwinde, Eppendorf AG, Germany

Dr Joerg (Jörg) Schwinde |  | Eppendorf AG » speaking at Vaccine Europe

Dr Darin Seehafer, Clinical Scientist/Program Director, PRA Health Sciences, United States

Dr Darin Seehafer | Clinical Scientist/Program Director | PRA Health Sciences » speaking at Vaccine Europe

Dr Ruud Segers, Executive Director, Clinical Research & Head Global Swine Biologicals R&D, MSD Animal Health, Netherlands

Dr Ruud Segers | Executive Director, Clinical Research & Head Global Swine Biologicals R&D | MSD Animal Health » speaking at Vaccine Europe

Dr Katherine Shives, R&D Scientist, Sartorius-Stedim-Biotech, United States

Dr Katherine Shives | R&D Scientist | Sartorius-Stedim-Biotech » speaking at Vaccine Europe

Ricardo Silva, Researcher, iBET – Instituto de Biologia Experimental e Tecnológica, Portugal

Ricardo Silva | Researcher | iBET – Instituto de Biologia Experimental e Tecnológica » speaking at Vaccine Europe

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services, Belgium

Bruno Speder | Head of Clinical Regulatory Affairs | SGS – Life Science Services » speaking at Vaccine Europe

Prof Daniel Speiser, Head of Clinical Tumour Biology and Immunotherapy Group, University of Lausanne, Switzerland

Prof Daniel Speiser | Head of Clinical Tumour Biology and Immunotherapy Group | University of Lausanne » speaking at Vaccine Europe

Julia Spencer, Executive Director, Global Vaccine Policy & Government Relations, MSD, United States

Julia Spencer | Executive Director, Global Vaccine Policy & Government Relations | MSD » speaking at Vaccine Europe

Dr Koert Stittelaar, Director Preclinical Services, Viroclinics Biosciences, Netherlands

Dr Koert Stittelaar | Director Preclinical Services | Viroclinics Biosciences » speaking at Vaccine Europe

Dr Christine Tait-Burkard, Assistant Professor, The Roslin Institute, United Kingdom

Dr Christine Tait-Burkard | Assistant Professor | The Roslin Institute » speaking at Vaccine Europe

Dr Sybil Tasker, Chief Medical Officer, Altimmune, United States

Dr Sybil Tasker | Chief Medical Officer | Altimmune » speaking at Vaccine Europe

Dr Mark Throsby, Chief Scientific Officer, Merus B.V., Netherlands

Dr Mark Throsby | Chief Scientific Officer | Merus B.V. » speaking at Vaccine Europe

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics, Netherlands

Dr Peter Timmerman | Chief Scientific Officer | Pepscan Therapeutics » speaking at Vaccine Europe

Dr Lincoln Tubbs, Director, Food Animal Vaccines R&D, Elanco Animal Health, United States

Dr Lincoln Tubbs | Director, Food Animal Vaccines R&D | Elanco Animal Health » speaking at Vaccine Europe

Aernout Van Haarst, Director of Scientific Affairs, Celerion, United Kingdom

Aernout Van Haarst | Director of Scientific Affairs | Celerion » speaking at Vaccine Europe

Dr Elly Van Riet, Head of Exploratory and Clinical Research, Intravacc, Netherlands

Dr Elly Van Riet | Head of Exploratory and Clinical Research | Intravacc » speaking at Vaccine Europe

Dr Joris Vandeputte, President, IABS, Belgium

Dr Joris Vandeputte | President | IABS » speaking at Vaccine Europe

Elisenda Viaplana, Senior Scientist, Zoetis, Spain

Elisenda Viaplana | Senior Scientist | Zoetis » speaking at Vaccine Europe

Dr Arne Von Bonin, Chief Scientific Officer, Vaxxilon AG, Switzerland

Dr Arne Von Bonin | Chief Scientific Officer | Vaxxilon AG » speaking at Vaccine Europe

Dr Jun Wang, Genentech/Roche Pharmaceuticals Division, Switzerland

Dr Jun Wang |  | Genentech/Roche Pharmaceuticals Division » speaking at Vaccine Europe

Professor Mark Wilcox, Professor of Medical Microbiology & Deputy-Chair, APRHAI, University of Leeds, United Kingdom

Professor Mark Wilcox | Professor of Medical Microbiology & Deputy-Chair, APRHAI | University of Leeds » speaking at Vaccine Europe

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services, Switzerland

Dr Adrian Wildfire | Project Director - Infectious Diseases & Viral Infection Unit | SGS Life Science Services » speaking at Vaccine Europe

Dr Paul Williams, Technical Manager, MSD Animal Health, United Kingdom

Dr Paul Williams | Technical Manager | MSD Animal Health » speaking at Vaccine Europe

Dr Dong Yu, Director and Function Head, GSK Vaccines, United States

Dr Dong Yu | Director and Function Head | GSK Vaccines » speaking at Vaccine Europe

Dr Giovanna Zanoni, Assistant Director, Immunology Unit, University Hospital in Verona Italy, Italy

Dr Giovanna Zanoni | Assistant Director, Immunology Unit | University Hospital in Verona Italy » speaking at Vaccine Europe

Fred Zepp, Medical Director and Chairman, University Medicine Mainz, Germany

Fred Zepp | Medical Director and Chairman | University Medicine Mainz » speaking at Vaccine Europe

Dr Mai-Britt Zocca, Chief Executive Officer and Founder, IO Biotech ApS, Denmark

Dr Mai-Britt Zocca | Chief Executive Officer and Founder | IO Biotech ApS » speaking at Vaccine Europe

Dr Alfredo Zurlo, Chief Medical Officer, Glycotope, Germany

Dr Alfredo Zurlo | Chief Medical Officer | Glycotope » speaking at Vaccine Europe

 

 

Sign Up for Event Updates